Armson A, Kamau S W, Grimm F, Reynoldson J A, Best W M, MacDonald L M, Thompson R C
Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia, Australia.
Acta Trop. 1999 Oct 15;73(3):303-11. doi: 10.1016/s0001-706x(99)00034-0.
Leishmania infantum promastigotes and amastigotes were axenically cultured and exposed to the known tubulin binding compounds, the dinitroanilines, trifluralin, benfluralin, pendimethalin, oryzalin and the precursor of the dinitroanilines, chloralin, as well as isomers of chloralin and trifluralin and to the benzimidazole, albendazole. Drug induced inhibition was observed using [3H]thymidine uptake compared with untreated controls. In vitro analysis demonstrated a significant difference in the activity of five of the seven dinitroanilines between both life cycle stages of L. infantum. The amastigotes were 20-times more sensitive to chloralin and its isomer than to the dinitroanilines whereas the promastigotes were similar in sensitivity to the dinitroanilines and to chloralin and its isomer. This interesting finding suggests that the dinitroaniline precursors may have different target sites in the amastigotes to those within the promastigotes. Additionally, both chloralin and its isomer, and to a lesser extent benfluralin, caused a substantial stimulation of thymidine incorporation (up to 50%) at low concentrations. Dose response analysis suggests that the dinitroanilines may have more than one mode of action against L. infantum amastigotes and promastigotes. The inhibitory effects of the dinitroanilines against L. infantum vary from previous findings using the dinitroanilines against other Leishmania spp. The 348 base pair DNA sequence coding for beta-tubulin from amino acid residues 132 to 248 was obtained for L. infantum and used to compare the in vivo efficacy of albendazole with predicted activity based on beta-tubulin sequences of known benzimidazole sensitive protozoa. The use of beta-tubulin sequence as a predictive model of benzimidazole activity is discussed with particular reference to L. infantum.
婴儿利什曼原虫前鞭毛体和无鞭毛体在无菌条件下培养,并暴露于已知的微管蛋白结合化合物,即二硝基苯胺类(氟乐灵、乙丁氟灵、二甲戊灵、安磺灵)、二硝基苯胺的前体(三氯乙醛)以及三氯乙醛和氟乐灵的异构体,还有苯并咪唑类(阿苯达唑)。与未处理的对照相比,使用[3H]胸苷摄取观察药物诱导的抑制作用。体外分析表明,在婴儿利什曼原虫的两个生命周期阶段之间,七种二硝基苯胺中的五种活性存在显著差异。无鞭毛体对三氯乙醛及其异构体的敏感性比对二硝基苯胺高20倍,而前鞭毛体对二硝基苯胺和三氯乙醛及其异构体的敏感性相似。这一有趣的发现表明,二硝基苯胺前体在无鞭毛体中的靶位点可能与在前鞭毛体中的不同。此外,三氯乙醛及其异构体,以及在较小程度上乙丁氟灵,在低浓度下会导致胸苷掺入的显著刺激(高达50%)。剂量反应分析表明,二硝基苯胺对婴儿利什曼原虫无鞭毛体和前鞭毛体可能有不止一种作用方式。二硝基苯胺对婴儿利什曼原虫的抑制作用与之前使用二硝基苯胺对其他利什曼原虫属的研究结果不同。获得了编码婴儿利什曼原虫β-微管蛋白第132至248位氨基酸残基的348个碱基对DNA序列,并用于比较阿苯达唑的体内疗效与基于已知对苯并咪唑敏感的原生动物β-微管蛋白序列预测的活性。特别参考婴儿利什曼原虫讨论了使用β-微管蛋白序列作为苯并咪唑活性预测模型的问题。